The Definitive Peptide Research Reference Guide — Compound Review

HomeGuidesPeptides for Anti-Aging
Longevity Research · Aging Biology

Peptides for Anti-Aging

A mechanistic guide to 8 peptide compounds studied for longevity, cellular aging, immune senescence, and biological age reversal — grounded in the hallmarks of aging framework.

Telomere research included
Immune senescence coverage
FDA-approved compounds included

Aging Mechanisms These Compounds Target

Telomere Attrition

Epithalon activates telomerase to elongate telomeres — the protective caps on chromosomes that shorten with each cell division and are a primary driver of cellular senescence.

Mitochondrial Dysfunction

NAD+ and MOTS-c restore mitochondrial energy production and activate sirtuins — the master regulators of cellular stress response and metabolic health.

Immunosenescence

Thymosin Alpha-1 reverses age-related immune decline by restoring T-cell maturation and reducing chronic low-grade inflammation (inflammaging).

Tissue Remodeling Decline

GHK-Cu activates 4,000+ repair genes, restoring the tissue remodeling capacity that declines with age and drives skin aging, organ fibrosis, and wound healing impairment.

Neurodegeneration

Semax and Selank elevate BDNF/NGF and modulate stress pathways — addressing the neuroinflammation and HPA axis dysregulation that accelerate cognitive aging.

Epigenetic Alterations

NAD+-dependent sirtuins (SIRT1, SIRT6) are among the most studied epigenetic regulators of aging — their activity is directly dependent on cellular NAD+ availability.

The Hallmarks of Aging Framework

The 2023 updated hallmarks of aging (López-Otín et al., Cell) identifies 12 interconnected processes that drive biological aging. Unlike single-target pharmaceutical approaches, peptide research in longevity often addresses multiple hallmarks simultaneously — for example, NAD+ restoration improves both mitochondrial function (hallmark 7) and DNA repair capacity via PARP activation (hallmark 1). This systems-level approach is one reason the peptide longevity space has attracted significant research interest in the past decade.

High Evidence
Moderate Evidence
Emerging Evidence

Compound Profiles

1

GHK-Cu (Copper Peptide)

Moderate Evidence
Copper-Binding Tripeptide
Mechanism

Activates over 4,000 genes involved in tissue remodeling; stimulates collagen, elastin, and glycosaminoglycan synthesis; activates antioxidant enzymes (SOD, catalase); modulates TGF-beta and VEGF signaling

Key Research Finding

Gene expression studies show GHK-Cu upregulates genes associated with tissue repair and downregulates genes associated with inflammation and cancer progression; topical and systemic forms studied for skin aging reversal

Half-life: ~1–2 hours (free peptide); longer when copper-boundPrimary target: Skin aging / collagen synthesis / gene expression
2

Epithalon (Epitalon)

Moderate Evidence
Tetrapeptide / Telomerase Activator
Mechanism

Stimulates pineal gland melatonin production; activates telomerase enzyme → elongates telomeres in somatic cells; regulates circadian rhythm and neuroendocrine function

Key Research Finding

Russian longevity research (Khavinson et al.) spanning 35+ years shows telomere elongation in cell cultures and extended lifespan in animal models; limited but notable human data on biomarker improvements in elderly subjects

Half-life: ~30 minutes (estimated)Primary target: Telomere length / pineal function / longevity biomarkers
3

NAD+ (Nicotinamide Adenine Dinucleotide)

High Evidence
Coenzyme / Sirtuin Activator
Mechanism

Essential cofactor for sirtuins (SIRT1–7) and PARPs — key regulators of DNA repair, mitochondrial biogenesis, and cellular stress response; NAD+ levels decline ~50% between ages 40–60

Key Research Finding

Multiple human trials show NAD+ precursor supplementation (NMN, NR) restores cellular NAD+ levels; Phase I/II trials demonstrate improvements in muscle function, insulin sensitivity, and inflammatory markers in older adults

Half-life: Varies by delivery method; IV administration provides immediate cellular availabilityPrimary target: Mitochondrial function / DNA repair / sirtuin activation
4

Thymosin Alpha-1

High Evidence
Thymic Peptide / Immune Modulator
Mechanism

Enhances T-cell maturation and function; stimulates dendritic cell differentiation; upregulates MHC class II expression; modulates Th1/Th2 balance; reduces chronic low-grade inflammation associated with immunosenescence

Key Research Finding

FDA-approved (as Zadaxin) in 35+ countries for hepatitis B, hepatitis C, and as an adjuvant for cancer vaccines; extensive human data on immune restoration in aging and immunocompromised populations

Half-life: ~2 hoursPrimary target: Immune senescence / T-cell function / inflammation
5

BPC-157

Moderate Evidence
Gastric Pentadecapeptide
Mechanism

Upregulates nitric oxide synthesis and VEGF; promotes angiogenesis and tissue repair; modulates dopamine and serotonin systems; anti-inflammatory via NF-κB pathway inhibition

Key Research Finding

Preclinical studies show systemic protective effects across multiple organ systems; gut-brain axis modulation relevant to age-related neurological and gastrointestinal decline

Half-life: ~4 hours (estimated)Primary target: Systemic tissue protection / gut health / neurological support
6

MOTS-c

Emerging Evidence
Mitochondrial-Derived Peptide
Mechanism

Activates AMPK → improves mitochondrial function and metabolic flexibility; translocates to nucleus under stress to regulate gene expression; circulating levels decline significantly with age

Key Research Finding

Preclinical studies show MOTS-c reverses age-related insulin resistance and extends lifespan in aged mice; serum MOTS-c levels are significantly lower in older vs younger humans

Half-life: ~2–4 hours (estimated)Primary target: Mitochondrial aging / metabolic health / longevity
7

Selank

Moderate Evidence
Anxiolytic Neuropeptide
Mechanism

Modulates GABA-A receptor activity; regulates BDNF expression; stabilizes enkephalin degradation; reduces HPA axis hyperactivation — addressing the chronic stress component of accelerated aging

Key Research Finding

Russian clinical trials show anxiolytic efficacy comparable to benzodiazepines without dependence; chronic stress is a well-established accelerator of biological aging via cortisol-mediated telomere shortening

Half-life: ~3–5 minutes (rapidly metabolized to active fragments)Primary target: Stress / neuroinflammation / HPA axis regulation
8

Semax

Moderate Evidence
ACTH-Derived Neuropeptide
Mechanism

Stimulates BDNF and NGF synthesis; enhances dopaminergic and serotonergic neurotransmission; neuroprotective against ischemia and oxidative stress; supports cognitive function and neuroplasticity

Key Research Finding

Russian clinical use for stroke recovery and cognitive decline; BDNF elevation is particularly relevant to age-related neurodegeneration and cognitive aging research

Half-life: ~5–7 minutes (rapidly metabolized to active fragments)Primary target: Cognitive aging / neuroprotection / BDNF elevation

Aging Hallmark Coverage

CompoundTelomeresMitochondriaImmuneNeuroEvidence
GHK-CuModerate
Epithalon✓✓Moderate
NAD+✓✓High
Thymosin Alpha-1✓✓High
BPC-157Moderate
MOTS-c✓✓Emerging
Selank✓✓Moderate
Semax✓✓Moderate

✓✓ = Primary mechanism · ✓ = Secondary/supporting effect · — = Not a primary target

Frequently Asked Questions

What are anti-aging peptides and how do they work?

Anti-aging peptides are amino acid chains that interact with biological pathways involved in the aging process. They work through several mechanisms: telomere maintenance (Epithalon activates telomerase), cellular energy restoration (NAD+ supports mitochondrial function and sirtuin activity), tissue repair and remodeling (GHK-Cu activates thousands of repair genes), immune system restoration (Thymosin Alpha-1 reverses immunosenescence), and neuroprotection (Semax, Selank support brain health). The most compelling compounds address multiple hallmarks of aging simultaneously.

What are the hallmarks of aging that peptides can address?

The 2023 updated hallmarks of aging framework identifies 12 core processes: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. Peptides in this guide address several of these: Epithalon targets telomere attrition; NAD+ addresses mitochondrial dysfunction and deregulated nutrient sensing; Thymosin Alpha-1 targets immunosenescence and chronic inflammation; MOTS-c addresses mitochondrial dysfunction and metabolic deregulation.

How does GHK-Cu affect gene expression?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has been studied extensively by Loren Pickart, who identified it as a natural plasma tripeptide that declines with age. Gene expression analyses show GHK-Cu modulates over 4,000 human genes — upregulating genes involved in tissue repair, anti-inflammatory responses, and antioxidant defense, while downregulating genes associated with cancer progression and inflammatory signaling. This broad genomic activity is unusual for a tripeptide and has made it one of the most studied compounds in longevity research.

What is the evidence for Epithalon extending lifespan?

Epithalon (Ala-Glu-Asp-Gly) was developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. The research spans over 35 years and includes in vitro studies showing telomerase activation and telomere elongation in human somatic cells, animal studies showing extended lifespan in rodents and fruit flies, and limited human observational data showing improvements in biomarkers of aging in elderly subjects. The telomerase activation mechanism is well-characterized; the translation to human longevity outcomes remains an active area of research.

Why does NAD+ decline with age and why does it matter?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell that is essential for over 500 enzymatic reactions, including those performed by sirtuins (SIRT1–7) and PARPs — the primary enzymes responsible for DNA repair and epigenetic regulation. NAD+ levels decline approximately 50% between ages 40 and 60, largely due to increased consumption by CD38 (an NAD+ hydrolase that increases with age-related inflammation) and reduced synthesis. This decline impairs mitochondrial function, DNA repair capacity, and cellular stress responses — all central to the aging process.

Can Thymosin Alpha-1 reverse immune aging?

Thymosin Alpha-1 is the most clinically validated peptide in this guide, with FDA approval (as Zadaxin) in over 35 countries. Immunosenescence — the progressive deterioration of immune function with age — is characterized by thymic involution, reduced naive T-cell output, and chronic low-grade inflammation (inflammaging). Thymosin Alpha-1 addresses this by enhancing T-cell maturation, stimulating dendritic cell function, and modulating the Th1/Th2 balance. Clinical data in elderly and immunocompromised populations show measurable improvements in T-cell counts and functional immune responses.

Related Guides & Compound Profiles

Key Published Research

Peer-reviewed studies from verified investigators — linked directly to PubMed

Anti-aging peptide research spans multiple independent research groups. GHK-Cu was discovered by Loren Pickart, PhD, at the University of California in 1973. Epithalon was developed by Prof. Vladimir Khavinson, MD, PhD, at the St. Petersburg Institute of Bioregulation and Gerontology. Thymosin Alpha-1 was characterized by Allan Goldstein, PhD, at George Washington University.

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

Pickart L, Vasquez-Soltero JM, Margolina A.

BioMed Research International·2015·207 citations·GHK-Cu comprehensive review
PMID 25883975

Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells

Khavinson VKh, Bondarev IE, Butyugov AA.

Bulletin of Experimental Biology and Medicine·2003·142 citations·Foundational Epithalon telomerase paper
PMID 12868286

Thymosin beta4: Actin-sequestering Protein Moonlights to Repair Injured Tissues

Goldstein AL, Hannappel E, Kleinman HK.

Trends in Molecular Medicine·2005·312 citations
PMID 15882612

The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance

Lee C, Zeng J, Drew BG, et al.

Cell Metabolism·2015·821 citations
PMID 25738459

All citations link to verified PubMed records. This site does not fabricate or assign authorship — only real published investigators are listed.

Research These Compounds at Purgo Labs

Third-party tested, ≥99% purity, COA with every batch.

Shop Anti-Aging Peptides ↗
Research Purposes Only. All information on this page is provided for educational and scientific reference purposes only. The compounds discussed are research chemicals not approved for human use, consumption, or therapeutic application, except where explicitly noted (Thymosin Alpha-1/Zadaxin has regulatory approval in specific countries for specific indications). This content does not constitute medical advice. Compound Review may receive affiliate compensation for purchases made through links on this page.
Compound Review

For research purposes only. Not medical advice.

Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.